Nouryon starts work on chloromethanes expansion in Germany
Nouryon (formerly AkzoNobel Specialty Chemicals) will start construction in May on a project to further increase capacity for chloromethanes at its site in Frankfurt, Germany, supporting growing global customer demand. The expansion is expected to be completed in 2020.

Nouryon
The company first increased chloromethanes production in Frankfurt in 2017; the new project will increase annual production capacity of the chloromethane methyl chloride by more than 30%. Methyl chloride is used for the manufacture of various construction materials, silicones, surfactants and pharmaceuticals.
“As well as investing in additional capacity, we will also make substantial upgrades to the facility, which will improve overall supply reliability for our customers and support their growth plans,” said Knut Schwalenberg, Managing Director Industrial Chemicals at Nouryon. “We have a leading position in the European chloromethanes market and this is a significant investment to strengthen that.”
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Aminocaproic_acid

Quantum algorithms for material, chemical and pharmaceutical research - HQS Quantum Simulations brings in 12 million euros in series A
Oxea Announces Price Increase for Polyols
Successful takevoer of Schwarz Pharma by UCB
Evonik to expand its specialty silica capacities in Japan - Investment volume in the single-digit million Euro range
